Clinical Studies
Salvia BioElectronics initiated the first two studies to evaluate the safety and performance of Salvia’s bioelectronic foil for the preventive treatment of migraine and cluster headache.
Salvia’s device is not yet approved for commercial use. We make no claims about safety or effectiveness.
Migraine Study (RELIEF) in Belgium
The first evaluation of Salvia’s bioelectronic foil for people with chronic migraine is ongoing (“RELIEF”). Recruitment for this study is complete.
Cluster Headache Study (RESPONSE) in Australia
The first evaluation of Salvia’s bioelectronic foil for people with chronic cluster headache has started (“RESPONSE”). Recruitment is ongoing.
Salvia Insights
Starting in mid-2024, we will provide updates on our latest clinical trials and other developments. Stay informed about Salvia's mission?
We value your privacy and will only use your email to send you updates about Salvia BioElectronics. Your information will always remain confidential and will not be shared with third parties. You can unsubscribe at any time.